Galapagos NV
(NASDAQ : GLPG)

( )
GLPG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
1.01%296.831.4%$601.48m
AMGNAmgen, Inc.
0.32%236.741.3%$495.31m
GILDGilead Sciences, Inc.
-2.75%65.771.0%$370.34m
REGNRegeneron Pharmaceuticals, Inc.
1.15%376.422.6%$305.23m
VRTXVertex Pharmaceuticals, Inc.
-0.71%218.981.9%$275.99m
ILMNIllumina, Inc.
0.85%324.723.5%$241.12m
CLVSClovis Oncology, Inc.
-4.24%12.8614.7%$219.13m
SRPTSarepta Therapeutics, Inc.
31.43%132.0514.6%$207.70m
ALXNAlexion Pharmaceuticals, Inc.
-1.82%110.422.0%$199.61m
ARWRArrowhead Pharmaceuticals, Inc.
-1.28%66.4611.4%$199.52m
AAgilent Technologies, Inc.
-1.30%83.711.6%$164.84m
EXASEXACT Sciences Corp.
2.08%87.2024.0%$164.17m
BLUEbluebird bio, Inc.
6.78%89.7514.2%$152.73m
GBTGlobal Blood Therapeutics, Inc.
-0.01%76.886.0%$140.08m
BOLDAudentes Therapeutics, Inc.
0.05%59.401.4%$136.27m

Company Profile

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.